2017
DOI: 10.1097/tp.0000000000001603
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry

Abstract: The analysis of this (largest in the world) HEHE adult liver recipient cohort clearly confirms the value of LT in the treatment of this rare disorder and also permits identification of patients at risk of posttransplant recurrence. Posttransplant follow-up should take the HEHE-LT score into account. Extrahepatic disease localization is reconfirmed not to be a contraindication for LT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
50
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 79 publications
(54 citation statements)
references
References 41 publications
3
50
0
1
Order By: Relevance
“…Smaller studies included hEHE patients who underwent liver transplantation without extrahepatic disease, with very good outcomes. 8,[15][16][17] Systemic treatment for metastatic or progressed hEHE is still not well established. There is no consensus on the therapeutic algorithm which clinicians should follow.…”
Section: Discussionmentioning
confidence: 99%
“…Smaller studies included hEHE patients who underwent liver transplantation without extrahepatic disease, with very good outcomes. 8,[15][16][17] Systemic treatment for metastatic or progressed hEHE is still not well established. There is no consensus on the therapeutic algorithm which clinicians should follow.…”
Section: Discussionmentioning
confidence: 99%
“…LT is associated with greater blood loss, longer operating procedures, and longer hospital stay [ 20 ] when compared with LR. For patients receiving LT, the reported early (≤ 3 months) and late (> 3 months) mortality rates were 1% –5% and 22% [ 15 , 21 ], respectively, which were higher than the mortality rates of LR (0% –1%) [ 22 , 23 ]. In a previous case, multiple bone and spleen metastases developed within 3 months after LT [ 3 ], suggesting the possibility of occasional aggressive tumor recurrence after LT.…”
Section: Discussionmentioning
confidence: 99%
“…LT was recommended in those presenting with these risk factors. Lai et al analyzed data from the ELTR and proposed a risk score (HEHE-LT) to stratify patients to identify those who would benefit from LT according to risk of recurrence after transplantation (9). The risk factors associated with recurrence that were identified include pathological invasion of hilar lymph nodes and macrovasculature, and, interestingly, a short waiting time to transplantation (<120 days).…”
Section: Discussionmentioning
confidence: 99%